Liv Hospital integrates PET/CT diagnostics, radionuclide therapies and a multidisciplinary council to create individualized treatment plans for complex cancer and cardiac cases.
GRAND RAPIDS, Mich. — 3.3 million American men live with prostate cancer, according to Zero Prostate Cancer. That makes it the most commonly diagnosed cancer for men in the U.S. There is a fairly new ...
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today initiation of a Phase I clinical trial with 225 Ac-GPC3 (BAY 3547926), an investigational targeted alpha radiopharmaceutical being developed to ...
Sanofi is deepening its commitment to targeted radiation treatments for cancer with a €300 million equity investment in a new entity pursuing next-generation radioligand therapies. The new entity will ...
Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and clinical trial results at the 2025 American Society for Radiation Oncology (ASTRO) ...
UCLA scientists, together with a team of international collaborators, have identified a promising new treatment strategy that can detect, kill and reprogram aggressive, treatment-resistant tumors like ...
VALPARAISO | The most recent treatment Valparaiso resident John B. Scott had on two of his three cancerous tumors in his liver allowed him to be able to taste his food, a treat for the man who has ...
Nuclear medicine is a specialized discipline that evaluates the function and metabolism of organs using radiopharmaceuticals and advanced imaging systems. Unlike conventional imaging methods that ...
Telix Pharmaceuticals excels in radiopharmaceuticals, with strong revenue growth driven by imaging products like Illuccix and promising therapeutic programs in development. TLX's key imaging projects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback